Could a bone drug protect the brain? new trial for rare Fahr's disease
NCT ID NCT05662111
First seen Mar 09, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tests whether etidronate, a drug used for bone disorders, can slow or stop calcium buildup in the brain that causes Fahr's disease. About 98 adults with Fahr's will receive either the drug or a placebo for one year. The goal is to see if it preserves thinking, memory, and movement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAHR DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University College London Hospital
NOT_YET_RECRUITINGLondon, United Kingdom
Contact
Contact Phone: •••-•••-••••
-
University Medical Center Utrecht
RECRUITINGUtrecht, Utrecht, 3584 CX, Netherlands
Contact
Conditions
Explore the condition pages connected to this study.